New patent for Avadel Cns drug LUMRYZ

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for LUMRYZ
Annual Drug Patent Expirations for LUMRYZ

Lumryz is a drug marketed by Avadel Cns and is included in one NDA. It is available from one supplier. There are fifteen patents protecting this drug.

This drug has twenty-five patent family members in eleven countries.

The generic ingredient in LUMRYZ is sodium oxybate. One supplier is listed for this compound. Additional details are available on the sodium oxybate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top